Manulife (Manufacturers Life Insurance)
TNYA icon

Manulife (Manufacturers Life Insurance)’s Tenaya Therapeutics TNYA Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-23,199
Closed -$71.9K – 3054
2024
Q2 		$71.9K Buy
23,199
+7,000
+43% +$28.9K ﹤0.01% 2909
2024
Q1 		$84.7K Sell
16,199
-64,310
-80% -$308K ﹤0.01% 2816
2023
Q4 		$261K Sell
80,509
-10,478
-12% -$22.6K ﹤0.01% 2475
2023
Q3 		$232K Buy
90,987
+106
+0.1% +$444 ﹤0.01% 2511
2023
Q2 		$533K Buy
90,881
+49,402
+119% +$287K ﹤0.01% 1992
2023
Q1 		$118K Hold
41,479
– – ﹤0.01% 2707
2022
Q4 		$78.9K Sell
41,479
-6,488
-14% -$15.8K ﹤0.01% 2851
2022
Q3 		$144K Buy
47,967
+117
+0.2% +$546 ﹤0.01% 2705
2022
Q2 		$246K Sell
47,850
-4,369
-8% -$35.3K ﹤0.01% 2514
2022
Q1 		$609K Buy
+52,219
New +$632K ﹤0.01% 2069

Other funds holding TNYA

CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s TNYA Position: Q3 2024 in Review

Manulife (Manufacturers Life Insurance) sold out of Tenaya Therapeutics (TNYA) in Q3 2024, closing a stake of 23,199 shares — an estimated $71.9K sold.

Manulife (Manufacturers Life Insurance) first reported a position in TNYA in Q1 2022 and held it in 10 quarters. The position peaked at $609K in Q1 2022. 95 funds tracked by Wall St. Rank hold TNYA as of Q3 2024.

  • Manulife (Manufacturers Life Insurance) reported no remaining Tenaya Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 23,199 Tenaya Therapeutics shares in Q3 2024, an estimated $71.9K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Tenaya Therapeutics in Q1 2022 and held it in 10 quarters.
  • Manulife (Manufacturers Life Insurance)'s Tenaya Therapeutics position peaked at $609K in Q1 2022.
  • 95 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q3 2024.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q3 2024, filed 13 Nov 2024.